Moore Capital Management’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Moore Capital Management’s Portfolio ANTH Stock Details ANTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-25,000	Closed	-$678K	–	574
2014 Q2	$678K	Hold	25,000	–	–	0.02%	371
2014 Q1	$670K	Sell	25,000 -3,100	-11%	-$78.7K	0.01%	343
2013 Q4	$690K	Buy	+28,100	New	+$724K	0.01%	325
2013 Q3	–	Sell	-31,250	Closed	-$926K	–	458
2013 Q2	$926K	Buy	+31,250	New	+$1.17M	0.02%	251

Other funds holding ANTH

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Moore Capital Management's ANTH Position: Q3 2014 in Review

Moore Capital Management sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q3 2014, closing a stake of 25,000 shares — an estimated $678K sold.

Moore Capital Management first reported a position in ANTH in Q2 2013 and held it in 4 quarters. The position peaked at $926K in Q2 2013. 35 funds tracked by Wall St. Rank hold ANTH as of Q3 2014.

Moore Capital Management reported no remaining Anthera Pharmaceuticals, Inc. position as of Q3 2014 after selling out during the quarter.
Moore Capital Management sold 25,000 Anthera Pharmaceuticals, Inc. shares in Q3 2014, an estimated $678K.
Moore Capital Management first reported a position in Anthera Pharmaceuticals, Inc. in Q2 2013 and held it in 4 quarters.
Moore Capital Management's Anthera Pharmaceuticals, Inc. position peaked at $926K in Q2 2013.
35 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q3 2014.

Based on Moore Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.